EKF Diagnostics Holdings plc

Company Profile

Company website
Sector
Medical Equipment and Services (Medical Equipment)
Description
EKF Diagnostics Holdings plc (AIM: EKF) is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.

Investor Access

24 Mar
Event information

Two presentations will take place on Tuesday 24 March 2026 at the following times, the first will be held online via the Investor Meet Company platform and the second will be held in-person in the City of London, full details below:

1.    Investor Meet Company online presentation

EKF management will provide a live online presentation relating to the final results via Investor Meet Company at 11:00am GMT on Tuesday 24 March 2026. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9:00am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet EKF via:
https://www.investormeetcompany.com/ekf-diagnostics-holdings-plc/register-investor
  
2.    In-person investor presentation

EKF management will provide an in-person presentation in the City of London relating to the Company's final results at 5.30pm GMT on Tuesday 24 March 2026, which is open to all existing and potential shareholders.

If you would like to attend, please contact Walbrook PR on 020 7933 8780 or email EKF@walbrookpr.com.

Venue
City of London and online
Time
Tuesday 24 March 2026 at 11:00am (GMT) and Tuesday 24 March 2026 at 5.30pm (GMT)
Financial Calendar
 Event  Date
Year End 31 December
Half  Year End 30 June
Preliminary Results 24 March
Interim Results 16 September
AGM* May

* Months based on previous announcements of this kind